SPY366.69-0.10 -0.03%
DIA300.06+0.88 0.29%
IXIC12,377.18+27.82 0.23%

Revolution Medicines Q3 EPS $(0.42) Up From $(6.08) YoY, Sales $12.66M Up From $12.51M YoY

Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(0.42) per share. This is a 93.09 percent increase over losses of $(6.08) per share from the same period last year. The company reported $12.66 million in

· 11/12/2020 07:37
Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(0.42) per share. This is a 93.09 percent increase over losses of $(6.08) per share from the same period last year. The company reported $12.66 million in sales this quarter. This is a 1.24 percent increase over sales of $12.51 million the same period last year.